Compounds > naltrexone

naltrexone and AIDS Seroconversion

naltrexone has been researched along with AIDS Seroconversion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blokhina, E; Chawarski, M; Desrosiers, A; Krupitsky, E; Schottenfeld, R; Zvartau, E1
Gastfriend, DR; Illeperuma, A; Krupitsky, E; Ling, W; Nunes, EV; Silverman, BL1

Trials

2 trial(s) available for naltrexone and AIDS Seroconversion

ArticleYear
Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.
    Drug and alcohol dependence, 2017, Mar-01, Volume: 172

    Topics: Adult; Female; HIV Seropositivity; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Psychiatric Status Rating Scales; Quality of Life; Russia; Substance Abuse, Intravenous; Young Adult

2017
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Lancet (London, England), 2011, Apr-30, Volume: 377, Issue:9776

    Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; HIV Seropositivity; Humans; Injections; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse Detection

2011